Table of Contents 1 Anemia Treatment Drugs Market Overview 1.1 Product Overview and Scope of Anemia Treatment Drugs 1.2 Classification of Anemia Treatment Drugs by Types 1.2.1 Global Anemia Treatment Drugs Revenue Comparison by Types (2019-2024) 1.2.2 Global Anemia Treatment Drugs Revenue Market Share by Types in 2018 1.2.3 Supplements 1.2.4 Antibiotics 1.2.5 Immunosuppressant 1.2.6 Bone Marrow Stimulants 1.2.7 Corticosteroids 1.2.8 Gene Therapy 1.2.9 Iron Chelating Agents 1.3 Global Anemia Treatment Drugs Market by Application 1.3.1 Global Anemia Treatment Drugs Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Iron deficiency anemia 1.3.3 Thalassemia 1.3.4 Aplastic anemia 1.3.5 Hemolytic anemia 1.3.6 Sickle cell anemia 1.3.7 Pernicious anemia 1.4 Global Anemia Treatment Drugs Market by Regions 1.4.1 Global Anemia Treatment Drugs Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Anemia Treatment Drugs Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Anemia Treatment Drugs Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anemia Treatment Drugs Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Anemia Treatment Drugs Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anemia Treatment Drugs Status and Prospect (2014-2024) 1.5 Global Market Size of Anemia Treatment Drugs (2014-2024) 2 Company Profiles 2.1 Bayer AG 2.1.1 Business Overview 2.1.2 Anemia Treatment Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Bayer AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.2 AMAG Pharmaceuticals 2.2.1 Business Overview 2.2.2 Anemia Treatment Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 AMAG Pharmaceuticals Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.3 Merck Sharp & Dohme Corp. 2.3.1 Business Overview 2.3.2 Anemia Treatment Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.4 Amgen, Inc. 2.4.1 Business Overview 2.4.2 Anemia Treatment Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Amgen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.5 Pfizer, Inc. 2.5.1 Business Overview 2.5.2 Anemia Treatment Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Pfizer, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.6 Hoffmann-La Roche Ltd. 2.6.1 Business Overview 2.6.2 Anemia Treatment Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.7 Akebia Therapeutics 2.7.1 Business Overview 2.7.2 Anemia Treatment Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Akebia Therapeutics Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.8 Janssen Pharmaceutical 2.8.1 Business Overview 2.8.2 Anemia Treatment Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Janssen Pharmaceutical Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.9 Novartis AG 2.9.1 Business Overview 2.9.2 Anemia Treatment Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Novartis AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.10 GlaxoSmithKline plc 2.10.1 Business Overview 2.10.2 Anemia Treatment Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 GlaxoSmithKline plc Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.11 Vifor Pharma Management, Ltd. 2.11.1 Business Overview 2.11.2 Anemia Treatment Drugs Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.12 FibroGen, Inc. 2.12.1 Business Overview 2.12.2 Anemia Treatment Drugs Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 FibroGen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) 3 Global Anemia Treatment Drugs Market Competition, by Players 3.1 Global Anemia Treatment Drugs Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Anemia Treatment Drugs Players Market Share 3.2.2 Top 10 Anemia Treatment Drugs Players Market Share 3.3 Market Competition Trend 4 Global Anemia Treatment Drugs Market Size by Regions 4.1 Global Anemia Treatment Drugs Revenue and Market Share by Regions 4.2 North America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 4.3 Europe Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 4.5 South America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 5 North America Anemia Treatment Drugs Revenue by Countries 5.1 North America Anemia Treatment Drugs Revenue by Countries (2014-2019) 5.2 USA Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 5.3 Canada Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 5.4 Mexico Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 6 Europe Anemia Treatment Drugs Revenue by Countries 6.1 Europe Anemia Treatment Drugs Revenue by Countries (2014-2019) 6.2 Germany Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 6.3 UK Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 6.4 France Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 6.5 Russia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 6.6 Italy Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Anemia Treatment Drugs Revenue by Countries 7.1 Asia-Pacific Anemia Treatment Drugs Revenue by Countries (2014-2019) 7.2 China Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 7.3 Japan Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 7.4 Korea Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 7.5 India Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 8 South America Anemia Treatment Drugs Revenue by Countries 8.1 South America Anemia Treatment Drugs Revenue by Countries (2014-2019) 8.2 Brazil Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 8.3 Argentina Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 8.4 Colombia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Anemia Treatment Drugs by Countries 9.1 Middle East and Africa Anemia Treatment Drugs Revenue by Countries (2014-2019) 9.2 Saudi Arabia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 9.3 UAE Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 9.4 Egypt Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 9.5 Nigeria Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 9.6 South Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) 10 Global Anemia Treatment Drugs Market Segment by Type 10.1 Global Anemia Treatment Drugs Revenue and Market Share by Type (2014-2019) 10.2 Global Anemia Treatment Drugs Market Forecast by Type (2019-2024) 10.3 Supplements Revenue Growth Rate (2014-2024) 10.4 Antibiotics Revenue Growth Rate (2014-2024) 10.5 Immunosuppressant Revenue Growth Rate (2014-2024) 10.6 Bone Marrow Stimulants Revenue Growth Rate (2014-2024) 10.7 Corticosteroids Revenue Growth Rate (2014-2024) 10.8 Gene Therapy Revenue Growth Rate (2014-2024) 10.9 Iron Chelating Agents Revenue Growth Rate (2014-2024) 11 Global Anemia Treatment Drugs Market Segment by Application 11.1 Global Anemia Treatment Drugs Revenue Market Share by Application (2014-2019) 11.2 Anemia Treatment Drugs Market Forecast by Application (2019-2024) 11.3 Iron deficiency anemia Revenue Growth (2014-2019) 11.4 Thalassemia Revenue Growth (2014-2019) 11.5 Aplastic anemia Revenue Growth (2014-2019) 11.6 Hemolytic anemia Revenue Growth (2014-2019) 11.7 Sickle cell anemia Revenue Growth (2014-2019) 11.8 Pernicious anemia Revenue Growth (2014-2019) 12 Global Anemia Treatment Drugs Market Size Forecast (2019-2024) 12.1 Global Anemia Treatment Drugs Market Size Forecast (2019-2024) 12.2 Global Anemia Treatment Drugs Market Forecast by Regions (2019-2024) 12.3 North America Anemia Treatment Drugs Revenue Market Forecast (2019-2024) 12.4 Europe Anemia Treatment Drugs Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Anemia Treatment Drugs Revenue Market Forecast (2019-2024) 12.6 South America Anemia Treatment Drugs Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Anemia Treatment Drugs Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Anemia Treatment Drugs Picture Table Product Specifications of Anemia Treatment Drugs Table Global Anemia Treatment Drugs and Revenue (Million USD) Market Split by Product Type Figure Global Anemia Treatment Drugs Revenue Market Share by Types in 2018 Figure Supplements Picture Figure Antibiotics Picture Figure Immunosuppressant Picture Figure Bone Marrow Stimulants Picture Figure Corticosteroids Picture Figure Gene Therapy Picture Figure Iron Chelating Agents Picture Table Global Anemia Treatment Drugs Revenue (Million USD) by Application (2014-2024) Figure Anemia Treatment Drugs Revenue Market Share by Applications in 2018 Figure Iron deficiency anemia Picture Figure Thalassemia Picture Figure Aplastic anemia Picture Figure Hemolytic anemia Picture Figure Sickle cell anemia Picture Figure Pernicious anemia Picture Table Global Market Anemia Treatment Drugs Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024) Table Bayer AG Basic Information, Manufacturing Base and Competitors Table Bayer AG Anemia Treatment Drugs Type and Applications Table Bayer AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table AMAG Pharmaceuticals Anemia Treatment Drugs Type and Applications Table AMAG Pharmaceuticals Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base and Competitors Table Merck Sharp & Dohme Corp. Anemia Treatment Drugs Type and Applications Table Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Amgen, Inc. Basic Information, Manufacturing Base and Competitors Table Amgen, Inc. Anemia Treatment Drugs Type and Applications Table Amgen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer, Inc. Anemia Treatment Drugs Type and Applications Table Pfizer, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors Table Hoffmann-La Roche Ltd. Anemia Treatment Drugs Type and Applications Table Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Akebia Therapeutics Basic Information, Manufacturing Base and Competitors Table Akebia Therapeutics Anemia Treatment Drugs Type and Applications Table Akebia Therapeutics Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Janssen Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Janssen Pharmaceutical Anemia Treatment Drugs Type and Applications Table Janssen Pharmaceutical Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Novartis AG Basic Information, Manufacturing Base and Competitors Table Novartis AG Anemia Treatment Drugs Type and Applications Table Novartis AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline plc Anemia Treatment Drugs Type and Applications Table GlaxoSmithKline plc Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Vifor Pharma Management, Ltd. Basic Information, Manufacturing Base and Competitors Table Vifor Pharma Management, Ltd. Anemia Treatment Drugs Type and Applications Table Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table FibroGen, Inc. Basic Information, Manufacturing Base and Competitors Table FibroGen, Inc. Anemia Treatment Drugs Type and Applications Table FibroGen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Global Anemia Treatment Drugs Revenue (Million USD) by Players (2014-2019) Table Global Anemia Treatment Drugs Revenue Share by Players (2014-2019) Figure Global Anemia Treatment Drugs Revenue Share by Players in 2017 Figure Global Anemia Treatment Drugs Revenue Share by Players in 2018 Figure Global Top 5 Players Anemia Treatment Drugs Revenue Market Share in 2018 Figure Global Top 10 Players Anemia Treatment Drugs Revenue Market Share in 2018 Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Anemia Treatment Drugs Revenue (Million USD) by Regions (2014-2019) Table Global Anemia Treatment Drugs Revenue Market Share by Regions (2014-2019) Figure Global Anemia Treatment Drugs Revenue Market Share by Regions (2014-2019) Figure Global Anemia Treatment Drugs Revenue Market Share by Regions in 2018 Figure North America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Europe Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure South America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table North America Anemia Treatment Drugs Revenue by Countries (2014-2019) Table North America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure North America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure North America Anemia Treatment Drugs Revenue Market Share by Countries in 2018 Figure USA Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Canada Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Mexico Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table Europe Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019) Figure Europe Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure Europe Anemia Treatment Drugs Revenue Market Share by Countries in 2018 Figure Germany Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure UK Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure France Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Russia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Italy Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table Asia-Pacific Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Share by Countries in 2018 Figure China Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Japan Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Korea Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure India Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Southeast Asia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table South America Anemia Treatment Drugs Revenue by Countries (2014-2019) Table South America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure South America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure South America Anemia Treatment Drugs Revenue Market Share by Countries in 2018 Figure Brazil Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Argentina Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Colombia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table Middle East and Africa Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries in 2018 Figure Saudi Arabia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure UAE Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Egypt Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure Nigeria Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Figure South Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019) Table Global Anemia Treatment Drugs Revenue (Million USD) by Type (2014-2019) Table Global Anemia Treatment Drugs Revenue Share by Type (2014-2019) Figure Global Anemia Treatment Drugs Revenue Share by Type (2014-2019) Figure Global Anemia Treatment Drugs Revenue Share by Type in 2018 Table Global Anemia Treatment Drugs Revenue Forecast by Type (2019-2024) Figure Global Anemia Treatment Drugs Market Share Forecast by Type (2019-2024) Figure Global Supplements Revenue Growth Rate (2014-2019) Figure Global Antibiotics Revenue Growth Rate (2014-2019) Figure Global Immunosuppressant Revenue Growth Rate (2014-2019) Figure Global Bone Marrow Stimulants Revenue Growth Rate (2014-2019) Figure Global Corticosteroids Revenue Growth Rate (2014-2019) Figure Global Gene Therapy Revenue Growth Rate (2014-2019) Figure Global Iron Chelating Agents Revenue Growth Rate (2014-2019) Table Global Anemia Treatment Drugs Revenue by Application (2014-2019) Table Global Anemia Treatment Drugs Revenue Share by Application (2014-2019) Figure Global Anemia Treatment Drugs Revenue Share by Application (2014-2019) Figure Global Anemia Treatment Drugs Revenue Share by Application in 2018 Table Global Anemia Treatment Drugs Revenue Forecast by Application (2019-2024) Figure Global Anemia Treatment Drugs Market Share Forecast by Application (2019-2024) Figure Global Iron deficiency anemia Revenue Growth Rate (2014-2019) Figure Global Thalassemia Revenue Growth Rate (2014-2019) Figure Global Aplastic anemia Revenue Growth Rate (2014-2019) Figure Global Hemolytic anemia Revenue Growth Rate (2014-2019) Figure Global Sickle cell anemia Revenue Growth Rate (2014-2019) Figure Global Pernicious anemia Revenue Growth Rate (2014-2019) Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Anemia Treatment Drugs Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Anemia Treatment Drugs Revenue Market Share Forecast by Regions (2019-2024) Figure North America Anemia Treatment Drugs Revenue Market Forecast (2019-2024) Figure Europe Anemia Treatment Drugs Revenue Market Forecast (2019-2024) Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Forecast (2019-2024) Figure South America Anemia Treatment Drugs Revenue Market Forecast (2019-2024) Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Forecast (2019-2024)

Bayer AG AMAG Pharmaceuticals Merck Sharp & Dohme Corp. Amgen, Inc. Pfizer, Inc. Hoffmann-La Roche Ltd. Akebia Therapeutics Janssen Pharmaceutical Novartis AG GlaxoSmithKline plc Vifor Pharma Management, Ltd. FibroGen, Inc.